07Jan/13

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites – News-Medical.net

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites
News-Medical.net
People with ascites are also often candidates for liver transplantation. Elijah Bolotin , PhD, President of PharmaIN, said, “Orphan-drug designation by the FDA indicates the importance of this new drug candidate to a desperately ill group of patients

and more »